Latest Articles
Jupiter woman faces 300% health insurance premium increase as subsidies expire - WFLX
Jupiter woman faces 300% health insurance premium increase as subsidies expire WFLX
Published: Nov. 4, 2025, 12:35 p.m.
CT radiomics-based explainable machine learning model for accurate differentiation of malignant and benign endometrial tumors: a two-center study - BioMedical Engineering OnLine
CT radiomics-based explainable machine learning model for accurate differentiation of malignant and benign endometrial tumors: a two-center study BioMedical Engineering OnLine
Published: Nov. 4, 2025, 11:50 a.m.
Jupiter woman faces 300% health insurance premium increase as subsidies expire - WPTV
Jupiter woman faces 300% health insurance premium increase as subsidies expire WPTV
Published: Nov. 3, 2025, 9:33 p.m.
TMC Life Sciences Poised for Growth Through Strategic Partnerships and Value-Based Care - Sin Chew Daily
TMC Life Sciences Poised for Growth Through Strategic Partnerships and Value-Based Care Sin Chew Daily
Published: Nov. 3, 2025, 7:20 a.m.
Scots woman faces hysterectomy fighting chronic disease that has 'ruined her life' - Yahoo News UK
Scots woman faces hysterectomy fighting chronic disease that has 'ruined her life' Yahoo News UK
Published: Nov. 2, 2025, 9:07 p.m.
Scots woman faces hysterectomy fighting chronic disease that has 'ruined her life' - Daily Record
Scots woman faces hysterectomy fighting chronic disease that has 'ruined her life' Daily Record
Published: Nov. 2, 2025, 2:36 p.m.
MSN Labs Gets SEC Go-Ahead to Conduct Phase IV Clinical Trial on Elagolix for Endometriosis - Medical Dialogues
MSN Labs Gets SEC Go-Ahead to Conduct Phase IV Clinical Trial on Elagolix for Endometriosis Medical Dialogues
Published: Nov. 1, 2025, 11:55 a.m.
FAK-dependent activation of src family kinase member BLK contributed to endometrial fibrosis via endoplasmic reticulum stress - Cell & Bioscience
FAK-dependent activation of src family kinase member BLK contributed to endometrial fibrosis via endoplasmic reticulum stress Cell & Bioscience
Published: Oct. 31, 2025, 9:23 a.m.
EVE Health Enters Commercial Rollout Phase for Dyspro and Libbo Following First Prescriptions and Purchase Orders - new.smallcaps.com.au
EVE Health Enters Commercial Rollout Phase for Dyspro and Libbo Following First Prescriptions and Purchase Orders new.smallcaps.com.au
Published: Oct. 31, 2025, 4:23 a.m.
Kissei Pharmaceutical’s Promising Phase III Study on Endometriosis Treatment - MSN
Kissei Pharmaceutical’s Promising Phase III Study on Endometriosis Treatment MSN
Published: Oct. 30, 2025, 11:45 a.m.
Link copied to clipboard!